Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Inovio Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($110.1M and $107.5M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against −54.8%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 16 metrics below, Inovio Pharmaceuticals, Inc. leads on 8 and Tonix Pharmaceuticals Holding Corp. on 8.

Valuation

Metric INO TNXP Biotechnology median
P/E n/m n/m 8.50
P/S 209.44 3.45 9.71
P/B 18.49 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.42 0.64
EV/Sales 157.45 (2.35) 9.21
Earnings yield (91.92%) (219.31%) (33.15%)
Free cash flow yield (99.09%) (157.36%) (25.50%)

Profitability

Metric INO TNXP Biotechnology median
Gross margin 100.00% 83.83% 65.16%
Operating margin 0.00% (568.43%) 0.00%
Net margin 0.00% (548.64%) 0.00%
Free cash flow margin 0.00% (543.29%) 0.00%
Return on equity (409.87%) (81.82%) (56.36%)
Return on assets (114.64%) (72.34%) (48.04%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric INO TNXP Biotechnology median
Revenue growth (TTM) (54.82%) 196.02% 6.02%
EPS growth (last fiscal year) 54.18% 91.75% 30.26%
Revenue growth, 5-year CAGR (61.18%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 6.61 4.72
Net debt to EBITDA 0.70 1.68 0.96

Dividend

Metric INO TNXP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INO TNXP Biotechnology median
Market cap 107.53m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack